Lyrica (Pregabalin)

Lyrica, known generically as Pregabalin, is a medication primarily used for epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It was originally discovered by medicinal chemist Richard Bruce Silverman at Northwestern University and was developed and brought to market by the pharmaceutical company Pfizer.

Starting in 2020, Pfizer spun off its Upjohn division (which held the off-patent brands like Lyrica) through a merger with Mylan to create a new global healthcare company called Viatris. Consequently, the commercial rights and ownership of Lyrica now fall under Viatris. Manufacturing for Lyrica takes place in various global facilities, with packaging for the European market often mentioning Upjohn EESV in the Netherlands as the marketing authorization holder.